These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 335216)

  • 21. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin.
    Hope WC; Welton AF; Fiedler-Nagy C; Batula-Bernardo C; Coffey JW
    Biochem Pharmacol; 1983 Jan; 32(2):367-71. PubMed ID: 6191762
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of mast cells in the pathogenesis of asthma.
    Holgate ST
    Bull Eur Physiopathol Respir; 1985; 21(5):449-62. PubMed ID: 2415192
    [No Abstract]   [Full Text] [Related]  

  • 23. Basic characteristics of human lung mast cell desensitization.
    MacGlashan D; Lichtenstein LM
    J Immunol; 1987 Jul; 139(2):501-5. PubMed ID: 2439588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slow-reacting substance of anaphylaxis (SRS-A) from lung tissue.
    Piper PJ; Tippins JR; Samhoun MN; Morris HR; Taylor GW; Jones CM; Sculley N; Rokach J; Girard Y
    Kroc Found Ser; 1981; 14():13-21. PubMed ID: 6947070
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulated production of slow reacting substances by mercaptans from ionophore A 23187-induced mononuclear cells: mercaptan structure-activity studies.
    Bach MK; Brashler JR
    Life Sci; 1978 Nov; 23(21):2119-26. PubMed ID: 31540
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure to obtain histamine release from rat mast cells exposed to human allergic serum and specific antigen or IgE myeloma protein and anti-IgE.
    Plaut M; Lichtenstein LM; Bloch KJ
    J Immunol; 1973 Oct; 111(4):1022-30. PubMed ID: 4125607
    [No Abstract]   [Full Text] [Related]  

  • 27. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung.
    Ishizaka T; Ishizaka K; Orange RP; Austen KF
    J Immunol; 1970 Feb; 104(2):335-43. PubMed ID: 4189671
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversed anaphylaxis with anti-IgE on mouse and rat mast cells.
    Wyczółkowska J; Brzezińska-Błaszczyk E; Michoń T; Maśliński C
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):559-64. PubMed ID: 6161595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells and their mediators.
    Marom Z; Casale TB
    Ann Allergy; 1983 Jun; 50(6):367-70. PubMed ID: 6190421
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of arachidonic acid in the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung fragments: evidence that SRS-A is very similar or identical structurally to nonimmunologically induced forms of SRS.
    Watanabe-Kohno S; Parker CW
    J Immunol; 1980 Aug; 125(2):946-55. PubMed ID: 6104681
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of mouse IgG and IgE homocytotropic antibodies in passive cutaneous anaphylaxis.
    Lehrer SB
    Immunology; 1977 Apr; 32(4):507-11. PubMed ID: 344200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells.
    Phillips MJ; Gold WM; Goetzl EJ
    J Immunol; 1983 Aug; 131(2):906-10. PubMed ID: 6306109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
    Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
    J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylserine enhancement of antigen-induced mediator release from rat mast cells.
    Stechschulte DJ; Austen KF
    J Immunol; 1974 Mar; 112(3):970-8. PubMed ID: 4130116
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative bioactivity of histamine and slow reacting substance of anaphylaxis released during anaphylactic reaction from different tissues of guinea pigs and rats.
    Shahani SR; Dhar HL
    Indian J Physiol Pharmacol; 1987; 31(2):107-10. PubMed ID: 2444537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchial asthma, leukocyte synthesis of slow-reacting substance of anaphylaxis, and other evidence for activation of blood cells in asthma.
    Grant JA; Lett-Brown MA
    J Allergy Clin Immunol; 1986 Mar; 77(3):407-10. PubMed ID: 2419381
    [No Abstract]   [Full Text] [Related]  

  • 39. Release of histamine and slow reacting substance with mast cell changes after challenge of human lung sensitized passively with reagin in vitro.
    Parish WE
    Nature; 1967 Aug; 215(5102):738-9. PubMed ID: 4168447
    [No Abstract]   [Full Text] [Related]  

  • 40. Release of slow-reacting substance of anaphylaxis in the rat: polymorphonuclear leukocyte.
    Orange RP; Valentine MD; Austen KF
    Science; 1967 Jul; 157(3786):318-9. PubMed ID: 6028400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.